黑龙江省人民政府办公厅印发《黑龙江省支持生物制造产业高质量发展若干政策措施》，其中提到，大 力发展生物化工。鼓励开发多元醇、长链二元酸、聚乳酸、聚酯、生物基尼龙等高技术含量、高附加值 的生物基化学品和材料，推动生物基产品在塑料包装、日化消费、交通物流、环保建材等领域应用。对 年度单品销售收入200万元以上的省重点新产品，按年度实际成交额的5%给予开发企业奖励，单品最高 奖励50万元，单户企业每年奖励累计最高300万元。 ...

Core Viewpoint - The strategic cooperation between Lude Technology and Guotou Juli Investment Management aims to enhance collaboration in the biomanufacturing sector, with a total investment of 117 million yuan in three subsidiaries focused on high-quality bio-fermented feed production [1][2]. Group 1: Investment Details - Guotou Juli's subsidiary, Juli Hangshi Fund, plans to invest 11.7 million yuan in Lude Technology's three bio-fermented feed subsidiaries: 35 million yuan in Bozhou Lude, 45 million yuan in Suqian Lude, and 37 million yuan in Yongle Lude [1]. - The investment is part of a broader strategy to support the development of the biomanufacturing industry, with the goal of increasing the industry's output value to 60 billion yuan by the end of the 14th Five-Year Plan [1]. Group 2: Company Transformation and Commitments - The three subsidiaries are central to Lude Technology's transition from environmental governance to high-tech biomanufacturing, utilizing by-products from the food industry to produce bio-fermented feed [2]. - Lude Technology commits to investing no less than 30 million yuan in research and development for protein feed resources between 2026 and 2028, with a sales target of at least 280,000 tons of bio-fermented feed made from liquor lees in 2026 [2]. - By 2028, Lude Technology aims for at least 10% of its soy sauce-flavored feed products to contain a protein content of no less than 26% [2]. Group 3: Strategic Advantages - The investment from Juli Hangshi Fund is expected to enhance Lude Technology's existing capacity and facilitate the planning of new capacities, transforming technological advantages into market and industrial advantages [2]. - Leveraging the strategic resources of the Guotou system will allow Lude Technology to integrate more deeply into the national biomanufacturing landscape, while collaboration with local investment funds will accelerate market expansion in key agricultural regions [2].

今日摘要 1、习近平总书记指出，粤港澳大湾区要围绕建设国际科技创新中心战略定位，努力建设全球科技创新 高地，推动新兴产业发展。今天的粤港澳大湾区深化合作、协同创新，向国际科技创新中心的"世界标 杆"加速迈进。 2、各地加强冬季田间管理。 3、"十四五"期间，我国生物制造产业规模稳步扩大。 4、系列报道【学习贯彻四中全会精神·一线见闻】今天播出：贵州推动高速公路服务区从单一"经停 站"向多元"消费场"转型。 5、11月份，我国实际使用外资同比增长26.1%。 6、日本民众举行抗议集会，要求高市早苗撤回错误言论，反对日本大幅增加防卫费。 7、俄罗斯总统表示，俄军已经完全掌握俄乌冲突战略主动权。乌克兰总统称，乌军不会在前线崩溃。 内容速览 【新思想引领新征程】粤港澳大湾区奋力打造全球科技创新高地 习近平总书记指出，粤港澳大湾区要围绕建设国际科技创新中心战略定位，努力建设全球科技创新高 地，推动新兴产业发展。今天的粤港澳大湾区，创新要素加速集聚，在深化合作中打开发展新天地，正 以坚实步伐向国际科技创新中心的"世界标杆"加速迈进。 科技助力 保障冬季田间管理提质增效 眼下，正值农业生产"冬管"关键期，各地因地制宜、科技 ...

Core Insights - Shenzhen has identified biomedicine, high-end medical devices, and the health industry as key sectors within the "20+8" industrial cluster, aiming to create a vibrant and complete ecosystem for pharmaceutical and medical device development [1][2] Industry Growth - The output value of Shenzhen's pharmaceutical and medical device industry is projected to increase from 128 billion yuan in 2020 to 157.6 billion yuan by 2024, with an average annual growth rate of 5.3% [1] - The medical device output is expected to rise from 83.1 billion yuan to 102.8 billion yuan, maintaining its position as the highest in the country [1] - By 2024, the total export value of pharmaceuticals and medical devices is anticipated to reach 41.38 billion yuan, with medical device exports alone accounting for 29.85 billion yuan, also the highest in the nation [1] Development Strategy - Shenzhen plans to establish an industrial development framework consisting of "one corridor, two zones, and three bases," focusing on biomedicine innovation and institutional innovation [2] - The "4+4+N" development strategy will target four emerging sectors, including cell and gene therapy, and will promote key projects in research and development as well as international expansion [2] Specialized Bases - The Pingshan District, recognized as a national-level biomedicine industrial base, has developed a support system with 13 specialized parks covering over 2.79 million square meters, achieving an annual compound growth rate of 39.8% in enterprise numbers [2] - The Guangming District has attracted over 900 medical device companies and over 100 biopharmaceutical companies, with the National Biomanufacturing Industry Innovation Center recently commencing operations to enhance collaborative innovation in the Greater Bay Area [3]

Core Insights - The Chinese biomanufacturing industry is projected to reach a scale of 1.01 trillion yuan in 2024, with a year-on-year growth of 15.4%. By 2030, the industry is expected to exceed 2.5 trillion yuan, with a compound annual growth rate of 16.8% [1]. Group 1: Industry Overview - The DT New Materials Research Institute has been actively monitoring and supporting the progress and innovation in the synthetic biology sector since the release of the "China Synthetic Biology Industry Map (2023)" which includes over 300 listed companies [1]. - The upcoming "4th Synthetic Biology and Green Biomanufacturing Conference (SynbioCon 2025)" will take place from August 20-22 in Ningbo, Zhejiang, where the "China Synthetic Biology Industry Distribution Map (2025 Edition)" will be announced, featuring over 500 representative biomanufacturing companies and their product information [1][9]. Group 2: Event Details - The conference will focus on five key areas: AI + Biomanufacturing, Green Chemistry and New Materials, Future Food, Future Agriculture, and Beauty Raw Materials, inviting industry leaders, experts, and various stakeholders to explore trends in biomanufacturing development during the 14th Five-Year Plan [9]. - Participants at the conference can receive a free copy of the industry map valued at 499 yuan, and eligible biomanufacturing companies can register to be included in the map [6][10].

Core Insights - The Chinese biomanufacturing industry is projected to reach a scale of 1.01 trillion yuan in 2024, with a year-on-year growth of 15.4%. By 2030, the industry is expected to exceed 2.5 trillion yuan, with a compound annual growth rate of 16.8% [1]. Group 1: Industry Development - The DT New Materials Research Institute has been actively monitoring and supporting the progress and innovation in the synthetic biology sector since the release of the "China Synthetic Biology Industry Map (2023)" which includes over 300 listed companies [1]. - The upcoming "4th Synthetic Biology and Green Biomanufacturing Conference (SynbioCon 2025)" will take place from August 20-22 in Ningbo, Zhejiang, where the "China Synthetic Biology Industry Distribution Map (2025 Edition)" will be announced, featuring over 500 representative biomanufacturing companies and their product information [1][9]. Group 2: Conference Details - The SynbioCon 2025 conference will focus on five key areas: AI + Biomanufacturing, Green Chemistry and New Materials, Future Food, Future Agriculture, and Beauty Raw Materials, inviting industry leaders, experts, and various stakeholders to explore the development trends of the biomanufacturing industry during the 14th Five-Year Plan [9]. - Participants at the conference will have the opportunity to receive a free copy of the industry map, valued at 499 yuan, and companies that qualify can apply to be listed on the global bio-based and biomanufacturing industry service platform [6][10].

Core Insights - Sinopec (Dalian) Petrochemical Research Institute is recruiting for 11 positions in key areas such as solid-state batteries, petrochemical artificial intelligence, bio-based monomers and materials, and synthetic biology, offering attractive annual salaries ranging from 500,000 to 2,000,000 CNY and 10 million CNY in research startup funding [1]. Group 1: Recruitment Details - The recruitment focuses on experts in synthetic biology, petrochemical engineering plastics, and bio-based monomers and materials [2][3][4]. - Each position requires a PhD, candidates aged between 30-50 years, and a minimum of 10 years of relevant work experience, with flexibility for outstanding candidates [5][5][5]. Group 2: Job Responsibilities and Requirements - Responsibilities include formulating strategic plans for carbon gas bioconversion, developing strain modification and biocatalysis systems, and leading product development and market promotion [5]. - The positions also involve planning the development strategy for special engineering plastics and bio-based materials, with a focus on technology development and market promotion [5][5][5]. Group 3: Compensation and Benefits - The salary range is between 500,000 to 2,000,000 CNY per year, with additional relocation allowances of 1.2 to 5 million CNY for high-level talent [7]. - The company provides 10 million CNY in research startup funding, a well-equipped research team of 3-8 members, and various support for relocation, education, and employment for family members [7]. Group 4: Upcoming Events - The 4th Synthetic Biology and Green Bio-Manufacturing Conference (SynBioCon 2025) will be held from August 20-22, 2025, in Ningbo, Zhejiang, focusing on AI and bio-manufacturing, green chemicals, new materials, future food, agriculture, and beauty raw materials [8]. - The conference aims to explore the development trends in the bio-manufacturing industry and promote the transfer and transformation of scientific achievements [8].

Core Insights - The National Investment Group (国投) is establishing a dedicated CVC fund for the biomanufacturing industry, focusing on early-stage, small investments in hard technology to support strategic emerging industries and core technology breakthroughs [1][3] - The biomanufacturing industry is recognized as a new engine for economic growth, with the establishment of the National Investment Group's new protein biomanufacturing innovation center aimed at addressing bottlenecks in new protein research and industrialization [1][2] Group 1: Industry Development - The new protein, which does not rely on traditional livestock or fishery methods, is synthesized using innovative technologies like microbial fermentation, addressing the significant protein gap in China, where over 66% of grain imports are soybeans [2] - The shortage of edible protein has become a safety issue, prompting the government to promote a comprehensive approach to food resource development [2] Group 2: Investment and Funding - The National Investment Group has invested in 25 biomanufacturing companies, totaling over 4 billion yuan, and has established various government-guided funds to support the industry [4] - The National Investment Group's funds exceed 270 billion yuan, with investments in 424 specialized enterprises, supporting 120 companies to go public, which constitutes 10% of the total on the Science and Technology Innovation Board [3][4] Group 3: Strategic Initiatives - The establishment of the National Investment Group's Biomanufacturing Innovation Research Institute, with a registered capital of 6 billion yuan, marks a strategic initiative to cultivate the biomanufacturing industry [3] - The National Investment Group aims to achieve a total output value of 60 billion yuan in the biomanufacturing sector by the end of the 14th Five-Year Plan, focusing on various sub-sectors such as industrial strains and food additives [3]

Group 1 - The food industry in Hainan achieved significant growth in Q1, with 201 large-scale enterprises reporting industrial output and added value growth of 27.1% and 23.4% year-on-year, respectively [1] - The agricultural and sideline food processing industry was the main driver of this growth, with 140 enterprises in this sector experiencing industrial output and added value growth of 34.2% and 50.4% year-on-year, respectively [1] - Investment in these enterprises increased by 54.3% year-on-year, and profit growth from January to February reached 299.6% [1] Group 2 - The food industry is a traditional advantageous industry in Hainan, playing a crucial role in stabilizing the economy and society [2] - Hainan is focusing on digital transformation in traditional food manufacturing and has recognized brands like "椰树牌" and "海南椰品" as notable products [2] - The province is set to launch the "Three-Year Action Plan for the Biological Manufacturing Industry in Hainan," aiming to enhance the quality of food products and capitalize on opportunities in the biological manufacturing sector [2]